Human Herpesvirus-6 and -7 After Lung and Heart-Lung Transplantation

Journal of Heart and Lung Transplantation

Volumn 26, Issue 1, 2007, Pages 41-47

  Lehto, Juho T ^a,b   Halme, Maija ^a   Tukiainen, Pentti ^a   Harjula, Ari ^a   Sipponen, Jorma ^a   Lautenschlager, Irmeli ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b HYVINKÄÄ HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CYTOMEGALOVIRUS ANTIGEN PP65; GANCICLOVIR; MONOCLONAL ANTIBODY; VALGANCICLOVIR; VIRUS ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ANTIGEN SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; FEMALE; HEART LUNG TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; INFECTION PREVENTION; LEUKOCYTE; LUNG LAVAGE; MALE; NONHUMAN; PATIENT MONITORING; PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; TREATMENT OUTCOME; VIRUS ACTIVATION; VIRUS ENCEPHALITIS;

ADULT; AGED; ANTIGENS, VIRAL; ANTIVIRAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HERPESVIRUS 6, HUMAN; HERPESVIRUS 7, HUMAN; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; ROSEOLOVIRUS INFECTIONS;

EID: 33846194256     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2006.10.017     Document Type: Article

References (39)

1. De Bolle L., Naesens L., and De Clercq E. Update on human herpesvirus 6 biology, clinical features and therapy. Clin Microbiol Rev 18 (2005) 217-245
2. Black J.B., and Pellet P.E. Human herpesvirus 7. Rev Med Virol 9 (1999) 245-262
3. Dockrell D.H. Human herpesvirus 6: molecular biology and clinical features. J Med Microbiol 52 (2003) 5-18
4. Dockrell D.H., and Paya C.V. Human herpesvirus-6 and -7 in transplantation. Rev Med Virol 11 (2001) 23-36
5. Levy J.A., Ferro F., Greenspan D., and Lennette E.T. Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population. Lancet 335 (1990) 1047-1050
6. Clark D.A., Freeland J.M.L., Mackie P.L.K., Jarrett R.F., and Onions D.E. Prevalence of antibody to human herpesvirus 7 by age. J Infect Dis 168 (1993) 251-252
7. Emery V.C. Human herpesviruses 6 and 7 in solid organ transplant recipients. Clin Infect Dis 32 (2001) 1357-1360
8. Jacobs F., Knoop C., Brancart F., et al. Human herpesvirus-6 infection after lung and heart-lung transplantation: a prospective longitudinal study. Transplantation 75 (2003) 1996-2001
9. Lautenschlager I., Linnavuori K., and Höckerstedt K. Human herpesvirus-6 antigenemia after liver transplantation. Transplantation 69 (2000) 2561-2566
10. Ljungman P. Beta-herpesvirus challenges in transplant recipients. J Infect Dis 186 suppl 1 (2002) S99-S109
11. Volin L., Lautenschlager I., Juvonen E., Nihtinen A., Anttila V.J., and Ruutu T. Human herpesvirus 6 antigenaemia in allogeneic stem cell transplant recipients: impact on clinical course and association with other beta-herpesviruses. Br J Haematol 126 (2004) 690-696
12. Yoshikawa T. Human herpesvirus 6 infection in haemapoietic stem cell transplant patients. Br J Haematol 124 (2004) 421-432
13. Lautenschlager I., Höckerstedt K., Linnavuori K., and Taskinen E. Human herpesvirus-6 infection after liver transplantation. Clin Infect Dis 26 (1998) 702-707
14. Singh N., Carrigan D.R., Gayowski T., and Marino I.R. Human herpesvirus-6 infection in liver transplant recipients. Documentation of pathogenicity. Transplantation 67 (1997) 674-678
15. Singh N. Human herpesviruses-6, -7 and -8 in organ transplant recipients. Clin Microbiol Infect 6 (2000) 453-459
16. Zerr D.M., Gupta D., Huang M.L., et al. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clin Infect Dis 34 (2002) 309-317
17. Humar A., Kumar D., Caliendo A.M., et al. Clinical impact of human herpesvirus 6 infection after liver transplantation. Transplantation 73 (2002) 599-604
18. Griffiths P.D., Ait-Khaled M., Bearcroft C.P., et al. Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus. J Med Virol 59 (1999) 496-501
19. Lautenschlager I., Lappalainen M., Linnavuori K., Suni J., and Höckerstedt K. CMV infection is usually associated with concurrent HHV-6 and HHV-7 antigenemia in liver transplant patients. J Clin Virol 25 suppl 2 (2002) S57-S61
20. Boutolleau D., Fernandez C., Andre E., et al. Human herpesvirus (HHV)-6 and HHV-7: Two closely related viruses with different infection profiles in stem cell transplantation recipients. J Infect Dis 187 (2003) 179-186
21. Razonable R.R., Rivero A., Brown R.A., et al. Detection of simultaneous beta-herpesvirus infections in clinical syndromes due to defined cytomegaloinfection. Clin Transplant 17 (2003) 114-120
22. De Clercq E., Naesens L., De Bolle L., Schols D., Zhang Y., and Neyts J. Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8. Rev Med Virol 11 (2001) 381-395
23. Yoshikawa T. Significance of human herpesviruses to transplant recipients. Curr Opin Infect Dis 16 (2003) 601-606
24. Mookerjee B.P., and Vogelsang G. Human herpesvirus-6 encephalitis after bone marrow transplantation: successful treatment with gancyclovir. Bone Marrow Transplant 20 (1997) 905-906
25. Michaelides A., Glare E.M., Spelman D.W., et al. β-herpesvirus (human cytomegalovirus and human herpesvirus 6) reactivation in at-risk lung transplant recipients and in human immunodefiency virus-infected patients. J Infect Dis 186 (2002) 173-180
26. Neurohr C., Huppmann P., Leuchte H., et al. Human herpesvirus 6 in bronchoalveolar lavage fluid after lung transplantation: a risk factor for bronchiolitis obliterans syndrome?. Am J Transplant 5 (2005) 2982-2991
27. The T.H., van der Berg A.P., Harmsen M.C., et al. The cytomegalovirus antigenemia assay: a plea for standardization. Scand J Infect Dis 99 suppl (1995) 25-29
28. Ljungman P., Griffiths P., and Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 34 (2002) 1094-1097
29. Razonable R.R., Brown R.A., Humar A., Covington E., Alecock E., and Paya C.V. Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease. J Infect Dis 192 (2005) 1331-1339
30. DesJardin J.A., Cho E., Supran S., Gibbons L., Werner B.G., and Snydman D.R. Association of human herpesvirus 6 reactivation with severe cytomegalovirus-associated disease in orthotopic liver transplant recipients. Clin Infect Dis 33 (2001) 1358-1362
31. Mendez J.C., Dockrell D.H., Espy M.J., et al. Human β-herpesvirus interactions in solid organ transplant recipients. J Infect Dis 183 (2001) 179-184
32. Brennan D.C., Gregory S.A., Singer G.G., Lee L., Ryeda J., and Schnitzler M.A. The prevalence of human herpesvirus-7 in renal transplant recipients is unaffected by oral or intravenous ganciclovir. J Infect Dis 181 (2000) 1557-1561
33. Härmä M., Loginov R., Piiparinen H., Halme L., Höckerstedt K., and Lautenschlager I. HHV-6-DNAemia related to CMV-DNAemia after liver transplantation. Transplant Proc 37 (2005) 1230-1232
34. Ross D.J., Chan R.C.K., Kubak B., Laks H., and Nichols W.S. Bronchiolitis obliterans with organizing pneumonia: possible association with human herpesvirus-7 infection after lung transplantation. Transplant Proc 33 (2001) 2603-2606
35. Osman H.K., Peiris J.S., Taylor C.E., et al. "Cytomegalovirus disease" in renal allograft recipients: is human herpesvirus 7 a co-factor for disease progression?. J Med Virol 48 (1996) 295-301
36. Zamora M.R., Davis R.D., and Leonard C. Management of cytomegalovirus infection in lung transplant recipients: evidence-based recommendations. Transplantation 80 (2005) 157-163
37. Strippoli G.F.M., Hodson E.M., Jones C., and Craig J.C. Pre-emptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients. Transplantation 81 (2006) 139-145
38. Zerr D.M., Gooley A., Yeung L., et al. Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients. Clin Infect Dis 33 (2001) 763-771
39. Jamil B., Nicholls K.M., Becker G.L., et al. Influence of anti-rejection therapy on the timing of cytomegalovirus disease and other infections in renal transplant recipients. Clin Transplant 14 (2000) 14-18